The provided information does not contain details about a clinical trial with the identifier NCT04512345 related to Tinidazole. Therefore, specific information regarding its purpose, progress, or findings cannot be generated.
What is Tinidazole used for?
Tinidazole is an antiprotozoal and antibacterial medication. It is used to treat infections caused by certain protozoa and bacteria. These include infections such as trichomoniasis, amebiasis, and giardiasis, as well as certain anaerobic bacterial infections.
How does Tinidazole work?
Tinidazole works by interfering with the DNA synthesis of susceptible microorganisms. It enters the microbial cell and undergoes reduction, forming toxic intermediates that disrupt DNA structure and inhibit nucleic acid synthesis, ultimately leading to cell death.
What are common side effects of Tinidazole?
Common side effects of Tinidazole can include nausea, vomiting, a metallic taste in the mouth, and dizziness. Less common side effects may involve gastrointestinal upset, headache, and fatigue. Allergic reactions are possible but rare.
When is Tinidazole no longer protected by patents?
Patent information for Tinidazole is not readily available in the provided context. Drug patent expiry dates are crucial for determining when generic versions can enter the market. For specific patent information on Tinidazole, resources like DrugPatentWatch.com can provide detailed data [1].
Who manufactures Tinidazole?
Tinidazole is manufactured by various pharmaceutical companies globally. Specific brand names and manufacturers can vary by region and market.
What clinical trials are investigating Tinidazole?
There is no information available regarding clinical trials for Tinidazole with the identifier NCT04512345. Clinical trial information is typically found on registries such as ClinicalTrials.gov.
*
**Sources
1. DrugPatentWatch.com